GTHRX Mutual Fund

GTHRX Mutual Fund

NAV$40.17
See how much of GTHRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing top 50 of 82 holdings · as of Aug 31, 2026
GTHRX holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
LLY
Eli Lilly & Co.Health Care · Pharmaceuticals
10.38%
10.4%111,322$128.77MHealth CarePharmaceuticals
2
JNJ
Johnson & Johnson -Health Care · Pharmaceuticals
6.82%
17.2%318,485$84.67MHealth CarePharmaceuticals
Sector and industry · Pro
3
UNH
Unitedhealth Group Inc
5.28%
22.5%168,361$65.56M
4
MRK
Merck & Company Inc
5.07%
27.6%425,626$62.89M
5
ABBV
AbbVie Inc.
4.00%
31.6%193,684$49.66M
6—Argenx Se Sponsored Adr (1 Ads : 1 Ordinary)
3.51%
35.1%42,230$43.57M
7
GILD
Gilead Sciences
3.31%
38.4%280,656$41.07M
8—Nvaesrtex Pharmaceuticals Inc
2.40%
40.8%54,714$29.79M
9
WELL
Welltower, Inc.
2.29%
43.1%120,441$28.45M
10
AMGN
Amgen Inc.
2.20%
45.3%63,470$27.28M
11
CVS
Cvs Health Corp.
2.20%
47.5%291,313$27.36M
12
TMO
Thermo Fisherscientific Inc.
2.18%
49.6%43,909$27.10M
13
RPRX
Royalty Pharma Plc Class A Ordinary Share
2.18%
51.8%440,990$27.08M
14
CAH
Cardinal Health Inc.
2.08%
53.9%110,152$25.84M
15
GH
Guardant Health, Inc
1.95%
55.9%152,178$24.20M
16
BTSG
Brightspring Health
1.92%
57.8%407,041$23.77M
17
EW
Edwards Lifesciences Corp
1.60%
59.4%219,094$19.88M
18
WAT
Waters Corp.
1.51%
60.9%45,153$18.72M
19
IQV
Iqvia Holdings Inc
1.43%
62.3%67,768$17.70M
20
AXSM
Axsome Therapeutics Inc
1.40%
63.7%87,700$17.41M
21DebtInvesco Short-term Investments Trust, Treasury Portfolio, Institutional Class 0.0102% 2021-01-07
1.40%
65.1%17,398,822$17.40M
22
NTRA
Natera Inc
1.37%
66.5%52,670$16.96M
23
BBIO
Bridgebio Pharma Inc_None_0
1.33%
67.8%216,227$16.56M
24
HALO
Halozyme Therapeutics Inc
1.33%
69.1%155,098$16.52M
25
CRL
Charles River Laboratories International Inc
1.28%
70.4%55,054$15.87M
26
PTGX
Protagonist Therapeutics Inc
1.24%
71.7%103,952$15.36M
27
RVMD
Revolution Medicines Inc
1.16%
72.8%69,866$14.36M
28
SDZ
Sandoz Group Ag
1.15%
74.0%169,209$14.21M
29
ASND
Ascendis Pharma A/S
1.15%
75.1%54,101$14.23M
30
LGND
Ligand Pharmaceuticals, Inc.
1.13%
76.3%49,408$14.04M
31
DGX
Quest Diagnostics Inc
0.99%
77.2%50,956$12.24M
32
ISRG
Intuitive Surgical Inc.
0.93%
78.2%30,687$11.56M
33
MDGL
Madrigal Pharmaceuticals Inc
0.92%
79.1%21,162$11.43M
34
MTD
Mettler-Toledo International Inc.
0.89%
80.0%7,844$11.02M
35
GALD
Galderma
0.83%
80.8%49,726$10.31M
36
WST
West Pharmaceutical Services Inc
0.77%
81.6%27,934$9.53M
37
TWST
Twist Bioscience Corp.
0.75%
82.3%67,195$9.34M
38
LH
Labcorp Holdings Inc
0.74%
83.1%27,780$9.24M
39
MEDP
Medpace Holdings Inc
0.74%
83.8%15,549$9.24M
40
AGPXX
Invesco Government & Agency Portfolio, Institutional Class
0.73%
84.5%9,016,356$9.02M
41
LONN
Lonza Group AG Ordinary Shares
0.70%
85.2%12,228$8.71M
42
THC
Tenet Healthcare Corp
0.68%
85.9%31,528$8.38M
43
CYTK
Cytokinetics Inc
0.62%
86.5%107,839$7.65M
44—Steris Plc Ordinary Shares
0.62%
87.2%33,121$7.71M
45
KRYS
Krystal Biotech Inc
0.59%
87.8%20,337$7.31M
46—Teva Pharmaceutical Industries Limited (Adr)
0.58%
88.3%200,906$7.24M
47
GMED
Globus Medical, Inc. (Class A)
0.57%
88.9%87,598$7.13M
48
ARWR
Arrowhead Pharmaceuticals Inc
0.54%
89.4%81,814$6.74M
49—Emcompass Health Corp
0.52%
90.0%53,477$6.43M
50
GKOS
Glaukos Corp.
0.52%
90.5%35,731$6.42M
More holdings · Pro
Not reported for this fund: share changes.
FundXLS Pro
See the other 32 holdings of GTHRX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime

GTHRX Mutual Fund All Holdings

GTHRX holdings total 81 positions. The top 10 holdings account for 45.3% of the fund, led by Eli Lilly & Co. at 10.4%, Johnson & Johnson - Common at 6.8%, Unitedhealth Group Incorporated at 5.3%.

GTHRX portfolio concentration is moderate, with the top 10 representing 45.3% of total assets. The largest sector exposure is Health Care at 88.6%.

GTHRX sectors provide a detailed breakdown. GTHRX overlap shows how holdings compare to other funds in your portfolio.